Alvotech (ALVOW) Research & Development (2021 - 2025)
Alvotech (ALVOW) reported Research & Development of $328.7 million for Q4 2025, up 291.87% on a YoY basis from $83.9 million in Q4 2024, and up 736.78% quarter-over-quarter from -$51.6 million in Q3 2025.
Alvotech (ALVOW) Research & Development (2021 - 2025) Analysis & Trends
Alvotech has reported Research & Development for 5 years, with the latest figure at $328.7 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 291.87% year-over-year to $328.7 million; the trailing twelve-month figure through Dec 2025 stood at $184.2 million (up 160.92% YoY), and the FY2025 full-year result was $184.2 million, up 7.52% from the prior year.
- Research & Development for Q4 2025 stood at $328.7 million, up from -$51.6 million in the prior quarter.
- The five-year high for Research & Development was $337.6 million in Q4 2021, with the low at -$210.8 million in Q4 2023.
- Historically, Research & Development has averaged -$33.4 million across 5 years, with a median of -$50.7 million in 2025.
- The largest YoY upside for Research & Development was 291.87% in 2025 against a maximum downside of 99900.0% in 2025.
- Alvotech's Research & Development stood at $337.6 million in 2021, then sank by 153.5% to -$180.6 million in 2022, then declined by 16.72% to -$210.8 million in 2023, then increased by 18.74% to -$171.3 million in 2024, then jumped by 291.87% to $328.7 million in 2025.
- The last three Research & Development figures came in at $328.7 million (Q4 2025), -$51.6 million (Q3 2025), and -$43.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 46.94 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 39.38 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | 328.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 328.70 Mn |
| Sep 30, 2025 | -51.62 Mn |
| Jun 30, 2025 | -43.02 Mn |
| Mar 31, 2025 | -49.87 Mn |
| Dec 31, 2024 | -171.31 Mn |
| Sep 30, 2024 | -33.57 Mn |
| Jun 30, 2024 | -97.43 Mn |
| Mar 31, 2024 | -49,868.00 |
| Dec 31, 2023 | -210.83 Mn |
| Aug 31, 2023 | -99.58 Mn |
| Jun 30, 2023 | -99.53 Mn |
| Mar 31, 2023 | -50,864.00 |
| Dec 31, 2022 | -180.62 Mn |
| Aug 31, 2022 | -86.88 Mn |
| Jun 30, 2022 | -39.75 Mn |
| Mar 31, 2022 | -47.14 Mn |
| Dec 31, 2021 | 337.61 Mn |
| Sep 30, 2021 | -56.20 Mn |